comparemela.com
  1. Home
  2. Live Updates
  3. Clinical Global Impression - Breaking News

Latest Breaking News On - Clinical global impression - Page 7 : comparemela.com

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSandy coombsMarisa borgasanoNational comorbidity survey replicationIcahn school of medicine at mount sinaiAmerican psychiatric associationAlkermes incExchange commissionSchizophrenia international research societyAlkermes pharma irelandLaboratory tests for opioid detectionIcahn schoolMount sinaiPharmacological treatmentsWaist circumferenceMetabolic parameters

Adjunctive Ketogenic Diet Aids Outcomes With Serious Mental Illness

Benefits seen across anthropometric, metabolic, biomarker, and psychiatric outcomes

United statesShebani sethiPsychiatry researchHealthday newsStanford medicineBrief psychiatric rating scaleClinical global impression

Adjunctive Ketogenic Diet Aids Outcomes With Serious Mental Illness

Researchers found improvements in metabolic health, with no participants meeting metabolic syndrome criteria by study conclusion.

United statesShebani sethiPsychiatry researchHealthday newsStanford medicineBrief psychiatric rating scaleClinical global impression

FDA Approves Iloperidone for Adults with Bipolar 1 Disorder

Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder.

Stephen stahlMihaelh polymeropoulosIloperidone fanaptVanda pharmaceuticals incUniversity of california san diegoVanda pharmaceuticalsCalifornia san diegoImage creditYoung mania rating scaleClinical global impressions severityClinical global impressionPharmaceutical fanaptPublished aprilVanda pharma

FDA Approves Iloperidone for Bipolar Disorder

The US Food and Drug Administration has approved iloperidone tablets (Fanapt) for the treatment of bipolar disorder in adults.

Mihaelh polymeropoulosVanda pharmaceuticalsDrug administrationMedscape medical newsYoung mania rating scaleClinical global impressions severityClinical global impression

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.